CPT code 52260 denotes a diagnostic cystoscopy performed under general or spinal anesthesia to inspect the urethra, prostatic urethra (in men), bladder interior, and ureteric orifices for evaluation of interstitial cystitis. This inpatient or outpatient operative procedure is clinically important because it provides direct visualization for diagnosing an often underrecognized chronic bladder pain syndrome and may guide subsequent treatment choices.

Key payers covered in this national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for use of this cystoscopic evaluation, expected sites of service, and common coding considerations. The publication also summarizes available benchmarks and payer coverage patterns where present, highlights relevant policy updates affecting surgical and ambulatory procedural billing, and outlines typical documentation elements that support medical necessity for this anesthetized diagnostic cystoscopy.

This article is intended for billing managers, coding professionals, clinical leaders, and policy analysts seeking a concise reference on clinical intent, service setting, and payer coverage implications for CPT code 52260 at a national level.